首页> 外国专利> pyrimidokinoxalinderivat, seen to framstella its, and lekemedel - those with allergic asthma

pyrimidokinoxalinderivat, seen to framstella its, and lekemedel - those with allergic asthma

机译:pyrimidokinoxalinderivat,见于其framstella和lekemedel-那些患有过敏性哮喘的人

摘要

Substituted pyrimido[5,6-b]quinoxaline-4(3H)-one-2-carboxylic acid compounds each represented by the formula IMAGE (I) wherein: R designates a member selected from the group consisting of hydrogen, alkyl groups having 1 to 4 carbon atoms, benzyl group, and phenyl group; and each of R1, R2, R3, and R4 independently designates a member selected from the group consisting of hydrogen, alkyl group having 1 to 4 carbon atoms, alkoxy groups having 1 to 4 carbon atoms, halogens, benzyloxy group, hydroxyl group, alkylthio groups having 1 to 4 carbon atoms, and alkylenedioxy groups having 1 to 4 carbon atoms and formed by the bonding of two of R1, R2, R3, and R4, or pharmacologically acceptable salts of said compounds.
机译:各自由式<图像>(I)表示的取代的嘧啶并[5,6-b]喹喔啉-4(3H)-一-2-羧酸化合物,其中:R表示选自氢,烷基的成员具有1-4个碳原子,苄基和苯基的碳原子; R 1,R 2,R 3和R 4各自独立地表示选自氢,碳数为1〜4的烷基,碳数为1〜4的烷氧基,卤素,苄氧基,羟基,烷硫基的成员。 R 1,R 2,R 3和R 4中的两个键合形成的具有1-4个碳原子的亚烷基和具有1-4个碳原子的亚烷基二氧基或所述化合物的药理学可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号